Search images on Google      Product Monograph

Active Ingredients:

• neisseria meningitidis grp b recombinant lipoprotein 2086 subfamily a, 60 MCG/0.5 ML
• neisseria meningitidis grp b recombinant lipoprotein 2086 subfamily b, 60 MCG/0.5 ML

DIN: 02468751

Dosage Form(s): SUSPENSION

Route(s) of Administration: INTRAMUSCULAR

Description: BIVALENT RECOMBINANT LIPOPROTEIN (RLP2086) - PREFILLED SYRINGE

Schedule: Schedule D

Company: PFIZER CANADA ULC

ATC:

• J07 - VACCINES (ATC, WHO, Wiki)
• J07A - BACTERIAL VACCINES (ATC, WHO)
• J07AH - Meningococcal vaccines (ATC, WHO)
• J07AH - MENINGOCOCCAL VACCINES (WHO)

Packaging:

• Package size unit: No information
• Package type: No information
• Package size: No information
• Product information: 1/10 SYR

 

External Links for Trumenba:

Search on Google

• Trumenba side effects
• Trumenba dosage
• neisseria meningitidis grp b recombinant lipoprotein 2086 subfamily a side effects
• neisseria meningitidis grp b recombinant lipoprotein 2086 subfamily a dosage
• neisseria meningitidis grp b recombinant lipoprotein 2086 subfamily b side effects
• neisseria meningitidis grp b recombinant lipoprotein 2086 subfamily b dosage